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EXTRACORPOREAL circulation (ECC) used during cardiac
surgery  causes  activation  of  several  inflammatory
systems.  These  events are not fully understood but
are responsible for complications during the immedi-
ate postoperative period. Neutrophil gelatinase-asso-
ciated lipocalin (NGAL), a member of the expanding
lipocalin family,  has recently been  described  as  an
inflammatory  protein.  In  this  study,  the  release  of
NGAL into the circulation in 41 patients undergoing
heart surgery with ECC was evaluated. A 4- to 5-fold
elevation of the concentration of NGAL in plasma was
observed during the immediate postoperative course
with  a  rapid  elimination  during  the  first  postoper-
ative  day.  Four  patients  undergoing  lung  surgery
(without ECC) were also studied. The plasma concen-
tration of NGAL only increased with a factor of 1.1–2.2
over the operation. We conclude that NGAL is released
into the circulation during heart surgery, probably as
a result of the inflammatory activation of leukocytes
initiated by the extracorporeal circulation.
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Introduction
Extracorporeal  circulation (ECC)  is  fundamental  for
cardiac surgery but it also induces a systemic inflam-
matory  response  which  may  cause  morbidity  and
mortality.1 Various inflammatory cascade systems are
activated  and  effects  are  seen  on  coagulation  and
fibrinolysis.  Activation  of  neutrophil  leukocytes
occurs  and  proteolytic  and  lysosomal  enzymes  are
released,  contributing  to  the  increased  vascular
permeability.2
Neutrophil  gelatinase-associated  lipocalin  (NGAL)
is a member of the recently described lipocalin family
and was named after co-purification  with leukocyte
gelatinase  from  secretory  granules  in  human  poly-
morphonuclear leukocytes.3–4 It has later also been
given  the  name  human  neutrophil  lipocalin,  HNL.5
NGAL  is  a  24-kDa  protein  and  exists  in  two  main
forms, as a monomer and as a dimer.4 –5 The function
of NGAL has yet to be clarified. Production of NGAL
has  been  demonstrated  in  in  vitro inflammatory
models. Our purpose was to elucidate whether NGAL
is released during extracorporeal circulation.
Patients
Forty-one elective patients undergoing elective heart
surgery with extra-corporeal circulation were studied
regarding possible release of NGAL. The male/female
ratio  was  31/10  and  the  median  age  was  62  years
(range,  36–79).  The  surgical  procedures  included
coronary  bypass  (32  patients),  valve  replacement
(seven patients) and coronary bypass+valve replace-
ment (two patients). The median time of extracorpor-
eal circulation was 83 min (range, 31–220)  and the
median  aortic  cross-clamp  time  was  50 min  (range,
14–118). The temperature during extracorporeal cir-
culation was 28°C.
Four  patients  undergoing  major  thoracic  surgery
without  the  use  of  ECC  were  also  studied. These
patients had lung resections via thoracotomy.
Methods
ECC  patients
Blood samples were drawn off into EDTA-containing
tubes preoperatively, 3 h after removal of the aortic
clamp and on the first and second postoperative days.
After centrifugation, plasma was separated and stored
at –30°C until analysed. Three samples were missing
from the second postoperative day.
Non-ECC  patients
The  corresponding  samples  were  drawn  but  the
second sample was collected 3 h after closure of the
skin.
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The  concentration  of  NGAL  was  determined  by an
enzyme-linked immunoassay.4
For  the  phagocytosis  experiment  2ml  human
serum and 4 3 109 yeast particles were incubated for
15 min at  37°C. The mixture was washed in  0.15 M
NaCl,  centrifuged  and  resuspended  to  a  volume  of
1 ml. The yeast was then incubated with 6.5 ml human
venous blood in constant shaking for 30 min at 37°C
followed  by centrifugation  at  300  3 g for 5 min. A
total of 200 m l of the supernatant  was separated on
Superose 12 using an HPLC system (LKB). Two patient
samples, with high concentration of NGAL, were also
selected for separation. The column was run at a flow
rate  of  0.8 ml/min  and  elution  volume  0.5 ml. The
fractions were tested with ELISA  for NGAL  content
and measured in a spectrophotometer at 405 nm. The
identification of the monomer and dimer was made
using Western blot as described previously.4
Statistics
Median values were calculated. Correlation between
time on cardiopulmonary bypass and levels of NGAL
was tested using the Spearman rank correlation test.
Differences in immediate NGAL release between ECC
and non-ECC patients was calculated using the Mann–
Whitney U-test.
The  study  was  approved  by  the  local  human
investigations  committee  at  Lund  University  and
informed consent was obtained.
Results
A 4- to 5-fold elevation of the plasma concentration of
NGAL was demonstrated after the use of cardiopulmo-
nary bypass (Fig. 1). The preoperative median concen-
tration  was  55 m g/l (range,  23–191). The  maximum
concentration  of  NGAL,  234m g/l  (range,  82–574),
was observed 3h after removal of the aortic clamp.
The level of NGAL at this point correlated to the time
on  cardiopulmonary  bypass  (r=0.37;  P=0.02).  The
median concentration of NGAL on postoperative day
1 was 101 m g/l (range, 36–637)  and 84 m g/l (range,
39–1011) on postoperative day 2. All patients but one
had lower levels of NGAL on postoperative days 1 and
2  compared  to  the  levels  3 h  after  removal  of  the
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FIG. 1. Median concentration of plasma-NGAL in samples
from  patients  operated  with  ECC  (d )  and  without  ECC  (s ).
FIG.  2.  Immunoreactive  NGAL  (measured  as  absorbance  at  405nm)  after  separation  on  HPLC  Superose  12.  Patient  sample  after
3h  (d )  and  postoperative  day  1  (3 )  and  in  vitro  activation  (s ).aortic cross-clamp. The only exception was a patient
with postoperative intermittent bleeding requiring a
re-operation a few days later due to massive haemo-
thorax. The  preoperative concentration of NGAL  in
plasma  in  this  patient  was  169 m g/l  and  the  post-
operative  values  were  574,  637  and  1011 m g/l,
respectively.
Patients undergoing thoracotomy and lung surgery
had  less  pronounced  increases  in  plasma  NGAL
concentration  during  the  immediate  postoperative
course  compared  to  patients  operated  with  ECC
(P<0.01). The 3-h levels were increased, compared to
the preoperative levels, by a factor of 1.1, 1.3, 1.4 and
2.2, respectively.
After chromatography, immunoreactive NGAL elu-
ted in two peaks. The first and smaller peak correlates
to  the  monomer,4 while  the  majority  of  immunor-
eactive NGAL was found as a dimer (Fig. 2).
Discussion
A few reports have been presented demonstrating the
release of NGAL in inflammatory diseases. Levels of
plasma-NGAL was elevated about 10 times in patients
with peritonitis. Very high levels, 37 mg/l, were found
in peritoneal exudates.4 Local liberation of NGAL has
been demonstrated in the gingiva during peridontitis6
and  in  colonic  epithelium  during  diverticulitis  and
appendicitis.7
Increased  plasma  levels  of  NGAL  have  also  been
found  in  patients  with  ischemic  cerebrovascular
diseases.8 Ischemic cardiac disease does not seem to
cause  release  of  NGAL  according  to  the  normal
preoperative values in our series where the majority
of the patients included needed coronary re-vascular-
isation. However, heart surgery induces liberation of
NGAL into the circulation. This is probably due to the
use of extracorporeal circulation, causing an inflam-
matory  response  including  the  activation  of  leuco-
cytes  since  the  patients  undergoing  major  thoracic
surgery  without  ECC  have  a  more  limited  initial
release of NGAL.
NGAL was circulating mainly in its dimer form.4The
significance  of  this  finding  has  to  be  further
evaluated.
The  turnover  of  intravenously  injected  human
NGAL in rats is fast.4 In the present series, the peak
plasma levels of NGAL, 3 h after removal of the aortic
clamp, is more than halved on the first postoperative
day. Thus, NGAL could be a useful indicator of the
current degree of neutrophil activation.
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